Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
T W LeBien , B Van Ness , W K Weng , D O'Brien
Journal of Immunology 159 ( 11) 5502 -5508
16
1997
Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
W K Weng , L Jarvis , T W LeBien
Journal of Biological Chemistry 269 ( 51) 32514 -32521
131
1994
Genetic Polymorphism of the Inhibitory IgG Fc Receptor FcγRIIb Is Not Associated with Clinical Outcome of Rituximab Treated Follicular Lymphoma Patients.
Wen-Kai Weng , Ronald Levy
Blood 106 ( 11) 2430 -2430
9
2005
Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma
Sally Arai , Renee Letsinger , Ruby M. Wong , Laura J. Johnston
Biology of Blood and Marrow Transplantation 16 ( 8) 1145 -1154
15
2010
Adoptive Immunotherapy with Cytokine Induced Killer Cells For Patients with Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
Ginna G. Laport , Kevin Sheehan , Jeanette Baker , Randall Armstrong
Biology of Blood and Marrow Transplantation 17 ( 11) 1679 -1687
106
2011
Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Wen-Kai Weng , Robert S. Negrin , Philip Lavori , Sandra J. Horning
Journal of Clinical Oncology 28 ( 2) 279 -284
70
2010
Autologous Cytokine-Induced Killer Cells as Post-Transplant Cellular Immunotherapy.
Sally Arai , Kevin Sheehan , Sherry Moore , Ginna Laport
Blood 110 ( 11) 580 -580
2
2007
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
Sally Arai , Bita Sahaf , Balasubramanian Narasimhan , George L. Chen
Blood 119 ( 25) 6145 -6154
89
2012
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Holbrook E Kohrt , Roch Houot , Kipp Weiskopf , Matthew J Goldstein
Journal of Clinical Investigation 122 ( 3) 1066 -1075
208
2012
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients†‡
Michael J. Kelly-Sell , Youn H. Kim , Suzanne Straus , Bernice Benoit
American Journal of Hematology 87 ( 4) 354 -360
42
2012
A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
Emilian Racila , Brian K. Link , Wen-Kai Weng , Thomas E. Witzig
Clinical Cancer Research 14 ( 20) 6697 -6703
132
2008
Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.
Wen-Kai Weng , Ronald Levy
Blood 98 ( 5) 1352 -1357
208
2001
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma
John M. Timmerman , Julie M. Vose , Debra K. Czerwinski , Wen-Kai Weng
Leukemia & Lymphoma 50 ( 1) 37 -46
31
2009
Genetic polymorphism of the inhibitory IgG Fc receptor FcgammaRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab.
Wen-Kai Weng , Ronald Levy
Leukemia & Lymphoma 50 ( 5) 723 -727
33
2009
Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma
Wen-Kai Weng , Wen-Kai Weng , Ronald Levy
Leukemia & Lymphoma 50 ( 9) 1494 -1500
28
2009
A Fully Human Anti-CD40 Antagonistic Antibody, CHIR-12.12, Inhibit the Proliferation of Human B Cell Non-Hodgkin’s Lymphoma.
Wen-Kai Weng , Xia Tong , Mohammad Luqman , Ronald Levy
Blood 104 ( 11) 3279 -3279
9
2004
Immunoglobulin G Fc Polymorphism Is Correlated with Rituximab-Induced Neutropenia Following Autologous Hematopoietic Cell Transplantation.
Wen-Kai Weng , Sandra J. Horning , Robert S. Negrin , Ronald Levy
Blood 104 ( 11) 442 -442
3
2004
Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype
Wen-Kai Weng , Debra Czerwinski , John Timmerman , Frank J. Hsu
Journal of Clinical Oncology 22 ( 23) 4717 -4724
194
2004
Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma
Wen-Kai Weng , Ronald Levy
Journal of Clinical Oncology 21 ( 21) 3940 -3947
1,183
2003
Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab, cetuximab, and rituximab.
Holbrook Edwin Kohrt , Roch Houot , Kipp Weiskopf , Matthew Goldstein
Journal of Clinical Oncology 30 2514 -2514
3
2012